166 related articles for article (PubMed ID: 22481252)
1. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
2. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Da Fonseca CO; Silva JT; Lins IR; Simão M; Arnobio A; Futuro D; Quirico-Santos T
Invest New Drugs; 2009 Dec; 27(6):557-64. PubMed ID: 19139816
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
4. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
5. Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.
Faria GM; Soares IDP; D'Alincourt Salazar M; Amorim MR; Pessoa BL; da Fonseca CO; Quirico-Santos T
BMC Cancer; 2020 Apr; 20(1):294. PubMed ID: 32264844
[TBL] [Abstract][Full Text] [Related]
6. Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy.
Silva MM; Da Fonseca CO; Moura-Neto R; Carvalho JF; Quirico-Santos T; Carvalho MG
Genet Mol Res; 2013 May; 12(2):1621-30. PubMed ID: 23765968
[TBL] [Abstract][Full Text] [Related]
7. Association between EGF +61 G/A and glioma risk in a Chinese population.
Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D
BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573
[TBL] [Abstract][Full Text] [Related]
8. EGF+61 A>G polymorphism is not associated with lung cancer risk in the Brazilian population.
Laus AC; de Paula FE; de Lima MA; Carlos CD; Gomes INF; de Marchi P; Valente JKN; Pioltini ABM; Miziara JE; da Silva CM; Viana LS; Scapulatempo-Neto C; Reis RM
Mol Biol Rep; 2019 Apr; 46(2):2417-2425. PubMed ID: 30783937
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
10. No association between EGF +61 A/G polymorphism and increased risk of glioma.
Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F
Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110
[TBL] [Abstract][Full Text] [Related]
11. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
12. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
13. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.
Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S
PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
15. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients.
Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V
Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629
[TBL] [Abstract][Full Text] [Related]
17. Association between functional EGF+61 polymorphism and glioma risk.
Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of genes for EGF, TGF-β and TNF-α in patients with pancreatic carcinoma.
Zhang L; Wu G; Herrle F; Niedergethmann M; Keese M
Cancer Genomics Proteomics; 2012; 9(5):287-95. PubMed ID: 22990108
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population.
Li Y; Zhao Y; Liu J; Liu P; Xu Y
Genet Test Mol Biomarkers; 2012 May; 16(5):449-52. PubMed ID: 22106858
[TBL] [Abstract][Full Text] [Related]
20. Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population.
Bao G; Wang M; Guo S; Han Y; Xu G
J Int Med Res; 2010; 38(5):1645-52. PubMed ID: 21309478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
